PHA 401
Chemotherapy of Microbial Diseases, Vaccines and Sera
2 Unit(s) (LH 30)
Course Description
At the end of the course, students should be able to:
1. state the definitions of the pharmacodynamic terms (bacteriostatic, bactericidal, time-
dependence and many others) used to describe the effects of antimicrobial therapy;
2. classify and explain the mechanisms of action, pharmacokinetics, adverse drug reactions,
contraindications of drugs used in the treatment of microbial and fungal diseases;
3. list the mechanisms by which pathogens acquire and express resistance to antibiotics;
4. classify and discuss the mechanisms of action, pharmacokinetics, adverse drug reactions,
drug interaction, contraindications other therapeutic indications of antiretroviral drugs; and
5. explain the rationale for the choice of a single and combination therapies in these disease
states.
Course Outline
Introduction: Terms and definitions of pharmacodynamic terms (bacteriostatic, bactericidal, time-
dependent and many others) used to describe the effects of antimicrobial therapythe mechanisms
by which pathogens acquire and express resistance to antibiotics.
Antibacterials/Antibiotics: The pharmacology of the following drugs: Sulphonamides. Beta-lactam
antibiotics (penicillins, cephalosporins, carbapenems, and monobactams). Tetracyclines.
Chloramphenicol. Aminoglycosides. Miscellaneous antibiotics - macrolides, polymyxins,
lincosamides, quinolones, metronidazole, bacitracin.
Antifungal and antiviral agents. Drugs used in the treatment of Tuberculosis and Leprosy
Antifungal agents. Antiviral agents; HIV/AIDS treatment. Vaccines design strategies and Sera.